學會概要

Customize Your Learning Experience!

Mix-and-match sessions from these additional co-located conferences at no additional cost:

• Process & Product Validation
• Technology Transfer for Biopharmaceuticals
• Outsourcing Manufacturing of Biopharmaceuticals
• Biopharmaceutical Raw Materials throughout the Product Lifecycle

Stay for the week so you can attend on Feb. 29 - March 2 for these conferences:

• Antibody Development & Production
• Recombinant Protein & Complex Biologic Development & Production
• Analytical Technologies for Biotherapeutic Development
• Biobetters & Biosimilars: Technologies & Development Strategies

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until February 3, 2012.
To book your room, call 1-800-HILTONS and mention that you are an IBC attendee at this event.

近幾年發生起因於外來性物質的事故，故監督機關強化監視，以供應鏈的所有部分來檢測原料、細胞培養的製程和設施是否遭病毒污染，然後作預防與改善的新技術及減輕風險策略的必要性益發高漲。

學會採用的話題

• 因應單株抗體、蛋白質及疫苗產品的風險之基本對策和策略
• 為了建構有效的病毒屏障之新策略和技術：查出未知的外來性物質之方法
• 奈米過濾和前置過濾：與新技術、驗證和法規有關的輔導手冊
• 制止病毒和精製超高純度病毒：製程和法規的影響
• 針對污染的個案研究和設施保護策略：教訓和矯正措施
• 細胞銀行、細胞株、細胞基質、培養基：檢查原料的重要性

特別演講

MMV Contamination: Detection, Root Cause Determination, and Corrective Actions
Mark D. Moody, Ph.D.
Vice President of Analytical Services
Merrimack Pharmaceuticals

Ways to Maximize Throughput in Virus Filtration
Jerome Bill Jr.
Engineer II, Purification Development
Genentech, Inc.

Applying a Risk-based Product Protection Strategy to a New Mammalian Cell Culture Bioprocessing Facility
Marie Murphy, Ph.D.
Microbiologist, Biotechnology Operations
Eli Lilly, Ireland

Testing Raw Materials for Adventitious Agents Prior to Use in Manufacturing
Sridhar Pennathur, Ph.D.
Senior Director, Biosafety Testing, Department of Quality Control
MedImmune, Inc.